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Abstract
Objectives Intranasal dexmedetomidine is a potentially effective anxiolytic but its role in pediatric laceration repair is only
emerging. Future trials and clinical adoption of intranasal dexmedetomidine depend on understanding pediatric emergency
providers’ practice patterns surrounding anxiolysis and perceived barriers to intranasal dexmedetomidine for anxiolysis during suture repair in children. Our objectives were to characterize these parameters to inform future research and facilitate
clinical adoption.
Methods We conducted an online survey of pediatric emergency physician members of Pediatric Emergency Research
Canada from September to December 2020. Questions pertained to perceptions of anxiolysis for suture repair, with a focus
on intranasal dexmedetomidine. The primary outcome was anxiolysis for suture repair. Data were reported using descriptive statistics.
Results The response rate was 155/225 (68.9%). During suture repair, 127/148 (86%) believed that > 25% of young children
experience distress requiring physical restraint. 116/148 (78%) would provide anxiolysis, mainly intranasal benzodiazepines
(100/148, 68%). Only 6/148 (4%) would provide intranasal dexmedetomidine but 95/148 (64%) would consider it if there
was evidence of benefit. The most common perceived barriers to intranasal dexmedetomidine included inadequate personal
experience (114/145, 79%) and lack of access (60/145, 41%).
Conclusions Most Canadian pediatric emergency providers believe that laceration repair in a young child is distressing.
Despite questionable efficacy, most would provide intranasal benzodiazepines, but would consider intranasal dexmedetomidine if there was evidence of benefit.
Keywords Laceration repair · Anxiolysis · Pediatrics · Procedural distress · Emergency department · Sedation ·
Dexmedetomidine
Résumé
Objectifs La dexmédétomidine intranasale est un anxiolytique potentiellement efficace mais son rôle dans la réparation
des lacérations en pédiatrie n'est qu'émergent. Les futurs essais et l'adoption clinique de la dexmédétomidine intranasale
dépendent de la compréhension des habitudes de pratique des urgentistes pédiatriques en matière d'anxiolyse et des obstacles
perçus à la dexmédétomidine intranasale pour l'anxiolyse pendant la réparation des sutures chez les enfants. Nos objectifs
étaient de caractériser ces paramètres pour éclairer les recherches futures et faciliter l'adoption clinique.
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Méthodes Nous avons mené un sondage en ligne auprès des médecins urgentistes pédiatriques membres de Recherche en
urgence pédiatrique Canada (Pediatric Emergency Research Canada) de septembre à décembre 2020. Les questions portaient
sur les perceptions de l'anxiolyse pour la réparation des sutures, en mettant l'accent sur la dexmédétomidine intranasale.
Le résultat principal était l'anxiolyse pour la réparation des sutures. Les données ont été rapportées à l'aide de statistiques
descriptives.
Résultats Le taux de réponse était de 155/225 (68,9 %). Pendant la suture, 127/148 (86 %) ont estimé que > 25 % des jeunes
enfants éprouvent une détresse nécessitant une contention physique. 116/148 (78 %) fourniraient une anxiolyse, principalement des benzodiazépines intranasales (100/148, 68 %). Seulement 6/148 (4 %) fourniraient de la dexmédétomidine intranasale, mais 95/148 (64 %) l’envisageraient s’il y avait une preuve de bénéfice. Les obstacles les plus fréquemment perçus
à la dexmédétomidine intranasale étaient une expérience personnelle insuffisante (114/145, 79 %) et un manque d'accès
(60/145, 41 %).
Conclusions La plupart des fournisseurs canadiens de services d’urgence pédiatriques croient que la réparation des lacérations
chez un jeune enfant est pénible. En dépit d'une efficacité douteuse, la plupart d'entre eux fourniraient des benzodiazépines
intranasales, mais envisageraient la dexmédétomidine intranasale s'il était prouvé qu'elle était bénéfique.
Clinician’s capsule
What is known about the topic?
Suture repair of lacerations is distressing for young
children and intranasal benzodiazepines have not been
shown to be consistently effective.
What did this study ask?
What are pediatric emergency clinicians’ perceptions
surrounding anxiolysis for suture repair of lacerations
in children?
What did this study find?
Most pediatric emergency clinicians (68%) would
use intranasal benzodiazepines rather than dexmedetomidine, citing lack of experience and access as
barriers.
Why does this study matter to clinicians?
Adoption of newer agents, such as intranasal dexmedetomidine will depend on quality evidence, improved
knowledge, and minimizing delays in management.

Introduction
Laceration repair accounts for almost half of procedures performed in the emergency department (ED) [1]. Although
lidocaine–epinephrine–tetracaine is commonly used in
children, behavioral distress remains common [2]. Societal bodies have recommended a combination of physical,
psychological, and pharmacological approaches to reduce
pain and distress for children undergoing brief diagnostic
and therapeutic procedures [3, 4]. Managing behavioral distress with mild sedatives may reduce the need to physically
restrain children to minimize movement, a tactic that has
been discouraged by the Canadian Paediatric Society [3].
Intranasal midazolam is the most commonly used agent
for procedural distress in children for laceration repair [5].
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However, evidence of benefit is inconsistent [6–8] and its
administration is poorly tolerated because it is noxious to
the nasal mucosa [9]. Other agents such as inhaled nitrous
oxide have shown benefit [10], but require a cooperative
patient and a gas scavenging system. Nitrous oxide may also
be challenging to use for certain facial lacerations. Dexmedetomidine is a selective alpha-2 receptor agonist that has
been increasingly studied in children [11] likely due to its
minimal deleterious cardiovascular and respiratory effects
[11]. Intranasal dexmedetomidine (dexmedetomidine) is
well tolerated and reportedly more effective than intranasal or oral midazolam in children undergoing intravenous
insertion [12, 13] and dental procedures [14]. For laceration
repair in children, a single study showed superior anxiolysis
compared to intranasal midazolam, albeit only to facilitate
initial positioning [2]. Exploring whether dexmedetomidine
is superior to midazolam requires an understanding of providers’ perceptions of the need for anxiolysis and perceived
barriers to clinical adoption of dexmedetomidine.
With the growing interest in dexmedetomidine for children [6], our objectives were to characterize pediatric emergency clinicians’ perceptions surrounding anxiolysis for
suture repair of lacerations in children. Our findings may
help inform the design of future trials of dexmedetomidine
and facilitate clinical adoption of this agent.

Methods
Study design and participants
This was an online survey that included all independently
practicing Canadian pediatric emergency physicians registered in the Pediatric Emergency Research Canada (PERC)
database as of September 2020. PERC is a network of
healthcare providers whose primary clinical, administrative,
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and academic appointments are within Canadian tertiary
care pediatric EDs.

Protocol
Potential respondents were contacted via email from October 1 to December 30, 2020. A Modified Dillman Tailored
Design Method was used to optimize responses [15]. A
pre-notification email was sent on day 0, followed by initial electronic survey dissemination on week 1, and subsequent dissemination on week 2, week 3, week 7 and week 9
(non-responders only). The survey was administered using
Research Electronic Data Capture (REDCap) [16]. Consent
to participate was implied by completion of any portion of
the survey. Respondents were offered a $5 Starbucks card.
To prevent duplicate entries, email addresses were assigned
unique ID numbers in REDCap and corresponding surveys
could be completed only once. The study received approval
from Western University's Health Sciences Research Ethics
Board.
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Statistical analysis
All surveys were analyzed whether completed or not. The
primary outcome was the proportion of respondents who
would administer anxiolysis for suture repair of the laceration depicted in the vignette. Secondary outcomes included
perceived barriers to dexmedetomidine, types of anxiolytic
strategies, and perceptions of anxiolysis. Categorical data
were summarized using percentages and frequencies. Continuous data were summarized using means and standard
deviations (SD). Data were analyzed using Excel (version
16.5, Microsoft).

Results
Respondents
The response rate was 155/225 (68.9%). Demographic data
are summarized in Table 1.

Instrument

Analgesia

The survey was available in both English and French (Supplementary Appendix). It included demographic questions and a vignette depicting a 3-year-old male with a
3 cm forehead laceration requiring suture repair. Related
to the vignette, respondents were asked: (i) whether they
would offer analgesia and anxiolysis, (ii) type of analgesic
and anxiolytic, (iii) perceptions surrounding analgesia and
anxiolysis, (iv) degree to which analgesia and anxiolysis
improved patient experience using a 100 mm Visual Analog
Scale (VAS) from 0 = “does not improve” to 100 = “very
much improves”, and (v) experience with and perceptions
surrounding intranasal dexmedetomidine to facilitate laceration repair. Response options were in the form of multiple choice, sliding scales, and free text. Free-text data were
coded independently by two co-investigators (KK, NP). Survey respondents were permitted to edit and skip questions.
The survey was developed using the approach outlined by
Burns et al. [17] using a five-member focus group, expert
opinion, and literature review. To ensure content validity, a
table of specifications was created to ensure each question
fell into at least one domain of interest and each domain contained a sufficient number of items. Focus group members
then ranked the questions by relevance to the research question. The survey was translated into French and checked for
domains of equivalence (conceptual, item, semantic, operational, and measurement). Finally, the survey was piloted
among three pediatric ED physicians who rated each question using a 5-item Likert scale for face validity, clarity,
length, comprehensiveness, and bias.

In the context of the vignette, 152/152 (100%) of respondents indicated they would provide analgesia. Topical anesthetic gels and subcutaneous local anesthetics were reported
by 148/151 (98.0%) and 74/151 (49.0%) of respondents,
respectively (Table 2). In general, respondents (n = 148)
believed that analgesia improved patient care experience to
large degree, with a mean of 93 mm (SD = 11) on the VAS.

Anxiolysis
116/148 (78%) of respondents stated they would provide
anxiolysis or sedation for the child in the vignette. Most
[100/148 (68%)] endorsed intranasal benzodiazepines, with
nitrous oxide and intravenous ketamine endorsed by 27/148
(18%) and 21/148 (14%), respectively. Only 4/148 (3%)
endorsed dexmedetomidine (Table 3).
Respondents generally believed that anxiolysis improved
the patient care experience to a large degree, with a mean of
83 mm (SD = 20) on the VAS. 127/148 (86%) reported that
greater than 25% of children experienced distress significant
enough to require physical restraint during laceration repair.
101/145 (70%) and 89/145 (61%) believed that a caregiver
or certified child life specialist, respectively, was usually
insufficient to alleviate distress. 114/144 (79%) disagreed
that “laceration repair using sutures would not cause significant enough distress to warrant anxiolysis”. The most
common barriers to providing anxiolysis, where respondents indicated “somewhat” or “strong agreement”, included
delayed discharge (72/147, 49%) and management (56/147,
38%) (Table 4). The most common perceived benefits of
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Table 1  Demographic
characteristics of respondents
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Demographic characteristic

n (%)

Level of certification (n = 141)
Royal College/Board Certified/Board Eligible pediatric emergency medicine
98 (70)
Royal College/Board Certified/Board Eligible emergency medicine
17 (12)
Family medicine
3 (2)
General Pediatrics
16 (11)
Canadian College of Family Physicians—Emergency Medicine
6 (4)
American Board of Pediatrics—Pediatric Emergency Medicine
1 (0.7)
Type of ED (n = 144)
Pediatric-only emergency department
135 (94)
General (adult and paediatric) tertiary care emergency department
13 (9)
General (adult and pediatric) community emergency department
5 (3)
General (adult and pediatric) urgent care clinic
4 (3)
Pediatric patients treated (less than 19 years of age) out of the patient population that participants routinely treated (n = 147)
Less than 20%
3 (2)
21–40%
9 (6)
41–60%
5 (3)
61–80%
1 (0.7)
80–100%
129 (88)
Years of experience as attending physician (n = 146)
> 20 years
39 (27)
16–20 years
24 (16)
11–15 years
30 (21)
6–10 years
30 (21)
Up to 5 years
23 (16)
Gender (n = 146)
Female
78 (53)
Male
66 (45)
Prefer not to answer
2 (1)
Number of laceration repairs performed/month (n = 146)
1–3
20 (14)
4–6
39 (27)
7–10
38 (26)
More than 10
49 (34)
I never perform laceration repairs
0 (0)
Province of Practice (n = 146)
Alberta
24 (16)
Ontario
53 (36)
Quebec
33 (23)
Manitoba
7 (5)
British Columbia
9 (6)
Nova Scotia
9 (6)
Newfoundland and Labrador
5 (3)
Saskatchewan
6 (4)
New Brunswick
0 (0)
Northwest Territories
0 (0)
Nunavut
0 (0)
Yukon
0 (0)
Prince Edward Island
0 (0)

Canadian Journal of Emergency Medicine (2022) 24:75–83
Table 2  Practice patterns
surrounding analgesia for
laceration repair in the 3-yearold male featured in the vignette
(n = 148)

79

Analgesic choices

n (%)

Local anesthetics
Topical anesthetic gel (e.g., lidocaine–epinephrine–tetracaine or LET)
Subcutaneous/injected local anesthetic (e.g., lidocaine, bupivacaine)
Regional anesthesia (e.g., nerve block)
Topical anesthetic cream (e.g., EMLA™, Ametop™, Maxilene™)
Oral analgesics
Oral non-opioid analgesic (e.g., acetaminophen and/or ibuprofen)
Oral ketorolac
Oral opioid analgesic
Intravenous analgesics
Intravenous non-opioid analgesic (e.g., ketorolac)
Intravenous opioid analgesic (e.g., morphine, fentanyl)
Intravenous ketamine
Intranasal analgesics
Intranasal opioid analgesic (e.g., fentanyl)

148 (100)
74 (50)
2 (1)
4 (3)
63 (44)
0 (0)
0 (0)
2 (1)
0 (0)
9 (6)
43 (29)

EMLA eutectic mixture of local anesthetics

Table 3  Practice patterns surrounding anxiolysis for laceration repair
in the 3-year-old male featured in the vignette (n = 148)
Anxiolytic choices
Oral
Benzodiazepine (e.g., midazolam)
Dexmedetomidine
Intranasal anxiolytics
Intranasal benzodiazepine
Intranasal dexmedetomidine
Intranasal ketamine
Intranasal fentanyl
Inhaled anxiolytics
Inhaled nitrous oxide
Inhaled methoxyflurane
Intravenous
Ketamine
Benzodiazepine (e.g., midazolam)
Propofol

n (%)
9 (6)
0 (0)
100 (68)
4 (3)
8 (5)
1 (0.7)
27 (18)
1 (0.7)

would consider dexmedetomidine if evidence suggested it
was effective at least 80% of the time. Important perceived
barriers to dexmedetomidine included inadequate personal
(114/145, 79%) and nursing (109/145, 75%) experience,
lack of access (60/145, 41%), prolonged time to sedation
(53/145, 37%) and recovery (44/145, 30%) (Table 5). Lack
of evidence was identified as a barrier by 24/145 (17%) of
respondents and 16/145 (11%) believed dexmedetomidine
to be cost-prohibitive.

Discussion
Interpretation

anxiolysis included improved patient (127/148, 86%) and
caregiver (132/148, 89%) satisfaction, a more cooperative
child with future medical procedures (121/148, 82%), and
improved provider morale and satisfaction (111/148, 75%).

Our national survey found that most Canadian pediatric
emergency providers believed that at least a quarter of
young children require physical restraint for suture repair
and would provide anxiolysis. Most would provide intranasal benzodiazepines. However, given the lack of consistent
efficacy of intranasal midazolam [6–8], our results suggest
that future research should explore more effective anxiolytic strategies for children undergoing laceration repair and
address barriers such as lack of provider experience, formulary access, and delayed management.

Intranasal dexmedetomidine

Previous studies

Most respondents had limited experience with dexmedetomidine, with 90/146 (62%) never having witnessed its
use in any practice setting. The mean comfort level with
dexmedetomidine by any route was 22 mm (SD = 28) on
the VAS (n = 146). However, 95/148 (64%) of respondents

Most respondents (78%) indicated they would use pharmacologic anxiolysis, most commonly (67%) intranasal benzodiazepines such as midazolam. This is consistent with
evidence that midazolam is the most frequently used anxiolytic for distressing procedures in children [7], including

21 (14)
1 (0.7)
4 (3)
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Table 4  Perceived barriers surrounding anxiolysis for laceration repair in the 3-year-old male featured in the vignette, n = 147 (%)

The time to produce effective anxiolysis/sedation will
delay management of the laceration repair
The time to recover from anxiolysis/sedation will
delay discharge of this patient
The route of administration (oral, intranasal, or intravenous) of an anxiolytic/sedative may cause more
discomfort than the laceration repair alone
The monitoring requirements are difficult in your
practice setting
The risks of providing an anxiolytic/sedative exceed
the benefit in laceration repair
Anxiolysis/sedation is not particularly effective for
children in this age group undergoing suture repair
of a laceration
Non-pharmacologic approaches (e.g., comfort measures) are sufficient for children in this age group
undergoing suture repair of a laceration
You are unfamiliar with anxiolysis/sedation options
for children in this age group undergoing suture
repair of laceration
Your practice setting does not support providing anxiolysis/sedation for laceration repair in this age group
Laceration repair using sutures will not cause significant enough distress to warrant anxiolysis/sedation

Strongly agree Somewhat agree Neither
agree nor
disagree

Somewhat disagree Strongly disagree

6

32

9

29

23

10

39

12

23

14

0

12

12

40

37

0.7

4

3

25

67

2

10

7

28

54

0

6

5

28

62

4

16

15

31

34

2

1

1

15

80

0

1

4

14

81

3 (2)

11 (8)

16 (11)

36 (25)

78 (54)

laceration repair [18]. Intranasal midazolam administered
via a mucosal atomizer device has a rapid onset of action;
achieving 90% of its maximum concentration in 5–17 min
[19], has a small intranasal volume requirement, and is
widely available. Intranasal midazolam has also been studied
extensively in children [7, 8, 18], and all these factors may
have influenced respondents’ willingness to use it. Notably,
trials have found conflicting results for oral or intranasal
midazolam to facilitate suture repair in children [20–22]. A
systematic review of 30 trials concluded there was insufficient high-quality evidence to determine whether midazolam
produces more effective sedation than chloral hydrate and
diazepam for therapeutic and diagnostic medical procedures
[7]. In addition, intranasal midazolam is often noxious to
the nasal mucosa and many children report a bitter taste in
the mouth [9, 23]. Not surprisingly, only 5% of respondents
endorsed intranasal ketamine. Although it has an emerging role for analgesia in pediatric musculoskeletal injuries
[24], there is little evidence of benefit in painful procedures
[25] and effective doses often require large intranasal volumes. Nevertheless, intranasal drugs potentially offer a less
distressing approach to medication delivery (compared to
intravenous) and are suitable for children unable or unwilling
to tolerate oral or inhaled therapy.
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Almost two thirds of respondents had no experience
with dexmedetomidine and indicated their comfort level
was low, not entirely surprising given that dexmedetomidine is not standard practice in Canadian pediatric EDs.
Data for dexmedetomidine in painful medical procedures
in children are limited to a few trials [14, 26] and one study
on initial positioning for suture repair [2]. Although dexmedetomidine appears to provide superior anxiolysis and
is better tolerated than chloral hydrate, and midazolam for
intravenous insertion [13, 26, 27] and dental procedures
[14], uncertainty remains as to whether it facilitates suture
repair [6]. Even though 64% of respondents would consider
dexmedetomidine if there was evidence of benefit, 17% cited
lack of evidence as a barrier. Prolonged time to effective
sedation and recovery were reported by 37% and 30% of
respondents, respectively. These are potentially important
barriers because dexmedetomidine’s onset and duration of
sedation can be up to 31 and 92 min, respectively [6], considerably longer than intranasal midazolam. Many sedative
agents including oral and intranasal benzodiazepines, chloral
hydrate, and dexmedetomidine are associated with length
of stays ranging from 50 to 144 min [2, 21, 22, 28–30].
Lidocaine–epinephrine–tetracaine has an onset of action
of 20–30 min [31], during which time, an anxiolytic can
theoretically be administered, possibly reducing delays

Canadian Journal of Emergency Medicine (2022) 24:75–83
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Table 5  Perceived barriers to using intranasal dexmedetomidine
(n = 145)

Strengths and limitations

Barrier1

n (%)

Inadequate personal experience with intranasal dexmedetomidine
Inadequate nursing experience with intranasal dexmedetomidine
Inadequate patient monitoring equipment
Inadequate physical space to provide anxiolysis/sedation
Lack of evidence supporting its effectiveness
Prolonged time to effective sedation
Prolonged time to recovery
Adverse effect profile
Patient unwillingness to receive anxiolysis/sedation
Caregiver unwillingness to receive anxiolysis/sedation
Nursing unwillingness to provide anxiolysis/sedation
Clinician unwillingness to provide anxiolysis/sedation
Inadequate access to intranasal atomizer devices
Inadequate access to dexmedetomidine in your practice
setting
Cost prohibitive
Other sedative agents have a more rapid onset/offset of
action
Other sedative agents have a superior safety profile
No perceived barriers

114 (79)

All respondents worked in tertiary care pediatric EDs, limiting the generalizability of our results. However, we may
have also selected respondents who had more opportunities
to be exposed to dexmedetomidine and therefore, greater
ability to identify barriers. Social desirability bias is inherent
to survey research [35] and may have led to over-reporting of
willingness to provide anxiolysis. A medical record review
may have provided more unbiased data related for practice
patterns surrounding anxiolysis. We used only one vignette
depicting a young child. Although younger children are more
likely to display more distress than older children [36], practice patterns surrounding anxiolysis likely vary across age
groups.

1

109 (75)
10 (7)
11 (8)
24 (17)
53 (37)
44 (30)
28 (19)
7 (5)
13 (9)
12 (8)
18 (12)
9 (6)
60 (41)
16 (11)
36 (25)
11 (8)
6 (4)

The response options were presented from a drop-down list

in management. In centers that apply lidocaine–epinephrine–tetracaine at triage, anxiolytic administration in the
ED can indeed contribute to delays in care. However, strategies employing best-evidence approaches to distress management have also been shown to decrease procedure time
[32]. Nurse initiated protocols for drug administration have
been used successfully to administer timely topical analgesia to manage needle-related pain in children [33]. Using a
similar approach, future work should explore the feasibility
of administering anxiolysis coincident with lidocaine–epinephrine–tetracaine to optimize timing of wound repair.
Including intranasal midazolam as a trial arm may inspire
practice change if dexmedetomidine is found to be superior.
Only 11% of respondents cited cost as a barrier to dexmedetomidine, but this may reflect unfamiliarity. Even with the
recent availability of a generic option, dexmedetomidine is
much more expensive than midazolam. A 2 mL (100 mcg/
mL) single-use vial of dexmedetomidine costs $45.20 CDN
versus $5.80 CDN for a 10 mL (5 mg/mL) single-use vial
of midazolam [34].

Clinical implications
Most pediatric ED clinicians believe that young children
experience distress associated with laceration repair. However, very few have experience with intranasal dexmedetomidine for anxiolysis. Clinical adoption of intranasal dexmedetomidine will depend on rigorous evidence of benefit
compared to the more frequently used benzodiazepines,
comprehensive knowledge translation, and the exploration
of strategies to minimize delays in care given its long duration of effect.

Research implications
Our findings suggest a need for studies exploring more effective strategies to reduce distress during laceration repair in
children. Future research should incorporate protocols that
minimize delays in management of lacerations.

Conclusions
This national survey found that most Canadian pediatric
physicians believe that at least a quarter of young children
require physical restraint for suture repair and would provide anxiolysis using intranasal benzodiazepines, despite
inconsistent evidence of benefit. However, pediatric ED clinicians would be willing to use intranasal dexmedetomidine
if research findings are favorable.
Supplementary Information The online version contains supplementary material available at https://doi.org/10.1007/s43678-021-00210-y.
Funding Department of Paediatrics Resident Research Grant.
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